Two Types of Receptors for 5-hydroxytryptamine on the Cholinergic Nerves of the Guinea-pig Myenteric Plexus
Overview
Authors
Affiliations
The effects of 5-hydroxytryptamine (5-HT) on spontaneous and electrically-evoked release of [3H]-acetylcholine (ACh) from guinea-pig myenteric plexus preparations preincubated with [3H]-choline have been investigated in the absence of cholinesterase inhibitors. 5-HT caused a transient increase in spontaneous release and an inhibition of the electrically-evoked release of [3H]-ACh. The 5-HT-induced contractions of the longitudinal muscle were clearly related to the increase in spontaneous release. The inhibitory effect was not due to activation of alpha-adrenoceptors since it was also observed in the presence of tolazoline and on strips from reserpine-pretreated guinea-pigs. After desensitization of the excitatory 5-HT receptors with 5-HT or metoclopramide the effects of 5-HT on spontaneous [3H]-ACh release were largely reduced. A variety of established antagonists at neuronal 5-HT receptors (i.e. metitepine 0.1-1 microM; methysergide 1 microM; ketanserin 0.1-1 microM; MDL 72222 0.1 microM; tropacocaine 1 microM) failed to block the excitation. The inhibition by 5-HT of the electrically evoked [3H]-ACh release was competitively antagonized by metitepine (pA2 7.6) and methysergide (pA2 7.0) but not by ketanserin. Tachyphylaxis to the inhibitory action of 5-HT did not occur. The results suggest that the excitatory 5-HT receptor ('M'-receptor) differs in its pharmacological properties from other neuronal 5-HT receptors. The presynaptically located inhibitory receptor may roughly correspond to the 5-HT1 receptor subtype but probably differs from the 5-HT autoreceptor.
Dietrich C, Kilbinger H Naunyn Schmiedebergs Arch Pharmacol. 1995; 351(3):237-43.
PMID: 7609776 DOI: 10.1007/BF00233242.
On the nature of the 5-HT receptor subtype inhibiting acetylcholine release in the guinea-pig ileum.
Ramirez M, Del Rio J, Cenarruzabeitia E, Lasheras B Br J Pharmacol. 1994; 113(1):77-80.
PMID: 7529115 PMC: 1510038. DOI: 10.1111/j.1476-5381.1994.tb16176.x.
Funk L, Trendelenburg A, Limberger N, Starke K Naunyn Schmiedebergs Arch Pharmacol. 1995; 352(1):58-66.
PMID: 7477426 DOI: 10.1007/BF00169190.
Kilbinger H Naunyn Schmiedebergs Arch Pharmacol. 1985; 331(4):311-5.
PMID: 4094622 DOI: 10.1007/BF00500812.
Sanger G Br J Pharmacol. 1987; 91(1):77-87.
PMID: 3594084 PMC: 1853491. DOI: 10.1111/j.1476-5381.1987.tb08985.x.